Homepage Insights News & Events News

A Swiss team advised Novartis International AG

Work highlight
08-09-2020
clock icon 1 minute read
Loyens & Loeff Switzerland advised Novartis International AG, a large Swiss multinational pharmaceutical company, with the Luxembourg law related elements in relation to the issuance of the first healthcare industry sustainability-linked notes via its Luxembourg subsidiary, Novartis Finance S.A.
Linkedin icon Twiter icon Mail icon
Expertises
Banking & Finance
Linkedin icon Twiter icon Mail icon
Branding icon

Contact us

Judith Raijmakers
Judith Raijmakers
Partner
Attorney at Law
Zurich
Return to previous slide
Go to next slide
Other recent news
  • Loyens & Loeff advised Foundever on its recapitalisation and refinancing
    20-08-2026
    Loyens & Loeff advised Foundever on its recapitalisation and refinancing
    Our Banking & Finance, Corporate and Tax teams advised Foundever on the Luxembourg and Dutch aspects of its significant recapitalisation and refinancing transaction.
    Work highlight
  • CRD VI: How can US lenders and banks continue to access EU corporate borrowers? – New York office Snippet
    14-08-2026
    CRD VI: How can US lenders and banks continue to access EU corporate borrowers? – New York office Snippet
    This is our latest Snippet on how US banks and lenders can continue to access EU corporate borrowers under CRD VI.  
    Blog
  • CRD VI: Belgium adopts new rules for third-country branches banking activities
    28-07-2026
    CRD VI: Belgium adopts new rules for third-country branches banking activities
    Belgium has adopted its CRD VI transposition law, introducing new branch authorisation requirements for certain third-country undertakings providing core banking services in Belgium from 11 January 2027.
    News
Logo Loyens & Loeff
Linkedin icon
Netherlands Belgium Luxembourg Switzerland
Legal & Privacy